Harnessing the Microbial World: Big Info in Small Packages

Using genomcs to develop new antibiotics and vaccines could help prepare for potential bioterrorist actions Although the Human Genome Project now draws more attention, the genomes of smaller organisms collectively contain more information. The American Association for the Advancement of Science's second annual Genome Seminar, held at this year's annual meeting in January in Anaheim, Calif., focused on analyzing that information for a myriad of purposes ranging from developing malaria vaccine s

Written byIlene Schneider
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Using genomcs to develop new antibiotics and vaccines could help prepare for potential bioterrorist actions
Although the Human Genome Project now draws more attention, the genomes of smaller organisms collectively contain more information. The American Association for the Advancement of Science's second annual Genome Seminar, held at this year's annual meeting in January in Anaheim, Calif., focused on analyzing that information for a myriad of purposes ranging from developing malaria vaccine strategies to discerning the origins of life.

Genomic data will continue rapidly accumulating as sequencing techniques and computing power keep advancing, noted J. Craig Venter, the two-day seminar's cochairman and chief scientific officer of Celera Genomics Corp., of Rockville, Md. Venter noted that since he and a team of scientists at The Institute for Genomic Research (TIGR), in Rockville, Md., finished the first genome, Haemophilus influenzae, in 1995,1 about 20 genomes have been completed, 80 more microbial genomes are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies